Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2013, Article ID 916837, 10 pages
http://dx.doi.org/10.1155/2013/916837
Review Article

Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells

1Molecular Cardiology Laboratory and Department of Cardiology, Fondazione Cardiocentro Ticino, Via Tesserete 48, 6900 Lugano, Switzerland
2Ultrastructural Pathology, “Victor Babeş” National Institute of Pathology, 99-101 Splainl Independentei, 050096 Bucharest 5, Romania
3Department of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), Avenue du Bugnon, 1011 Lausanne, Switzerland

Received 20 December 2012; Accepted 19 April 2013

Academic Editor: Pranela Rameshwar

Copyright © 2013 Lucio Barile et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Orlic, J. Kajstura, S. Chimenti et al., “Bone marrow cells regenerate infarcted myocardium,” Nature, vol. 410, no. 6829, pp. 701–705, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissmann, and R. C. Robbins, “Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium,” Nature, vol. 428, no. 6983, pp. 668–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Stamm, B. Westphal, H. D. Kleine et al., “Autologous bone-marrow stem-cell transplantation for myocardial regeneration,” The Lancet, vol. 361, no. 9351, pp. 45–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K. C. Wollert, G. P. Meyer, J. Lotz et al., “Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial,” The Lancet, vol. 364, no. 9429, pp. 141–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Schächinger, S. Erbs, A. Elsässer et al., “Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1210–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Assmus, J. Honold, V. Schächinger et al., “Transcoronary transplantation of progenitor cells after myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1222–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Janssens, C. Dubois, J. Bogaert et al., “Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial,” The Lancet, vol. 367, no. 9505, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Lunde, S. Solheim, S. Aakhus et al., “Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1199–1209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Leistner, U. Fischer-Rasokat, J. Honold et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy,” Clinical Research in Cardiology, vol. 100, no. 10, pp. 925–934, 2011. View at Publisher · View at Google Scholar
  11. P. Menasché, O. Alfieri, S. Janssens et al., “The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation,” Circulation, vol. 117, no. 9, pp. 1189–1200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. Duckers, J. Houtgraaf, C. Hehrlein et al., “Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial,” EuroIntervention, vol. 6, no. 7, pp. 805–812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., “Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial,” Journal of the American Medical Association, vol. 308, no. 22, pp. 2369–2379, 2012. View at Google Scholar
  14. J. Bartunek, M. Vanderheyden, B. Vandekerckhove et al., “Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety,” Circulation, vol. 112, no. 9, pp. I178–I183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Bartunek, A. Behfar, D. Dolatabadi et al., “Cardiopoietic stem cell therapy in heart failure the C-CURE multicenter randomized trial with lineage-specified biologics,” Journal of the American College of Cardiology, 2013. View at Publisher · View at Google Scholar
  16. J. H. Houtgraaf, W. K. den Dekker, B. M. van Dalen et al., “First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 59, no. 5, pp. 539–540, 2012. View at Publisher · View at Google Scholar
  17. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar
  18. R. R. Makkar, R. R. Smith, K. Cheng et al., “Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial,” The Lancet, vol. 379, no. 9819, pp. 895–904, 2012. View at Publisher · View at Google Scholar
  19. A. Abdel-Latif, R. Bolli, I. M. Tleyjeh et al., “Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis,” Archives of Internal Medicine, vol. 167, no. 10, pp. 989–997, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. C. Wollert and H. Drexler, “Cell therapy for the treatment of coronary heart disease: a critical appraisal,” Nature Reviews Cardiology, vol. 7, no. 4, pp. 204–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Chavakis, M. Koyanagi, and S. Dimmeler, “Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back,” Circulation, vol. 121, no. 2, pp. 325–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Dimmeler and A. Leri, “Aging and disease as modifiers of efficacy of cell therapy,” Circulation Research, vol. 102, no. 11, pp. 1319–1330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. C. Ott, T. S. Matthiesen, J. Brechtken et al., “The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells,” Nature Clinical Practice Cardiovascular Medicine, vol. 4, no. 1, pp. S27–S39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Bearzi, M. Rota, T. Hosoda et al., “Human cardiac stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068–14073, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Messina, L. De Angelis, G. Frati et al., “Isolation and expansion of adult cardiac stem cells from human and murine heart,” Circulation Research, vol. 95, no. 9, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. E. Roehrich, L. Barile, A. Spicher, M. Giacca, and G. Vassalli, “Characterization of cardiac-derived myelomonocytoid progenitor cells,” Journal of Stem Cell Research and Therapy, vol. S9, p. 002, 2012. View at Publisher · View at Google Scholar
  27. B. A. Reynolds and S. Weiss, “Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,” Science, vol. 255, no. 5052, pp. 1707–1710, 1992. View at Google Scholar · View at Scopus
  28. E. Pastrana, V. Silva-Vargas, and F. Doetsch, “Eyes wide open: a critical review of sphere-formation as an assay for stem cells,” Cell Stem Cell, vol. 8, no. 5, pp. 486–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. E. Roehrich and G. Vassalli, “Characterization of myelomonocytoid progenitor cells with mesenchymal differentiation potential obtained by outgrowth from pancreas explants,” Biotechnology Research International, vol. 2012, Article ID 429868, 12 pages, 2012. View at Publisher · View at Google Scholar
  30. L. T. Shenje, L. J. Field, C. A. Pritchard et al., “Lineage tracing of cardiac explant derived cells,” PLoS ONE, vol. 3, no. 4, Article ID e1929, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Steele, O. Y. Jones, F. Gok et al., “Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivo,” Journal of Heart and Lung Transplantation, vol. 24, no. 11, pp. 1930–1939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. B. G. Galvez, M. Sampaolesi, A. Barbuti et al., “Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle,” Cell Death and Differentiation, vol. 15, no. 9, pp. 1417–1428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. R. Davis, Y. Zhang, R. R. Smith et al., “Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue,” PLoS ONE, vol. 4, no. 9, Article ID e7195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Andersen, P. Andersen, M. Schneider, H. B. Jensen, and S. P. Sheikh, “Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential,” Stem Cells, vol. 27, no. 7, pp. 1571–1581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Altomare, L. Barile, S. Marangoni et al., “Caffeine-induced Ca2+ signaling as an index of cardiac progenitor cells differentiation,” Basic Research in Cardiology, vol. 105, no. 6, pp. 737–749, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Novak, C. Guo, W. Yang, A. Nagy, and C. G. Lobe, “Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision,” Genesis, no. 3-4, pp. 147–155, 2000. View at Google Scholar
  37. J. Ye, A. J. Boyle, H. Shih et al., “CD45-positive cells are not an essential component in cardiosphere formation,” Cell Tissue Research, vol. 351, no. 1, pp. 201–205, 2012. View at Publisher · View at Google Scholar
  38. R. R. Smith, L. Barile, H. C. Cho et al., “Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens,” Circulation, vol. 115, no. 7, pp. 896–908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Gaetani, M. Ledda, L. Barile et al., “Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields,” Cardiovascular Research, vol. 82, no. 3, pp. 411–420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Yamabi, H. Lu, X. Dai, Y. Lu, G. Hannigan, and J. G. Coles, “Overexpression of integrin-linked kinase induces cardiac stem cell expansion,” Journal of Thoracic and Cardiovascular Surgery, vol. 132, no. 6, pp. 1272–1279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. L. Tang, L. Shen, K. Qian, and M. I. Phillips, “A novel two-step procedure to expand cardiac Sca-1+ cells clonally,” Biochemical and Biophysical Research Communications, vol. 359, no. 4, pp. 877–883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Anversa, J. Kajstura, and A. Leri, “If I can stop one heart from breaking,” Circulation, vol. 115, no. 7, pp. 829–832, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. T. S. Li, K. Cheng, S. T. Lee et al., “Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair,” Stem Cells, vol. 28, no. 11, pp. 2088–2098, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Chimenti, R. R. Smith, T. S. Li et al., “Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice,” Circulation Research, vol. 106, no. 5, pp. 971–980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. T. S. Li, K. Cheng, K. Malliaras et al., “Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells,” Journal of the American College of Cardiology, vol. 59, no. 10, pp. 942–953, 2012. View at Publisher · View at Google Scholar
  48. K. Cheng, D. Shen, J. Smith et al., “Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction,” Biomaterials, vol. 33, no. 10, pp. 2872–2879, 2012. View at Publisher · View at Google Scholar
  49. K. Malliaras, T. S. Li, D. Luthringer et al., “Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells,” Circulation, vol. 125, no. 1, pp. 100–112, 2012. View at Publisher · View at Google Scholar
  50. S. F. Mause and C. Weber, “Microparticles: protagonists of a novel communication network for intercellular information exchange,” Circulation Research, vol. 107, no. 9, pp. 1047–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Mathivanan, H. Ji, and R. J. Simpson, “Exosomes: extracellular organelles important in intercellular communication,” Journal of Proteomics, vol. 73, no. 10, pp. 1907–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. P. J. Quesenberry and J. M. Aliotta, “Cellular phenotype switching and microvesicles,” Advanced Drug Delivery Reviews, vol. 62, no. 12, pp. 1141–1148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Mathivanan and R. J. Simpson, “ExoCarta: a compendium of exosomal proteins and RNA,” Proteomics, vol. 9, no. 21, pp. 4997–5000, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Sahoo, E. Klychko, T. Thorne et al., “Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity,” Circulation Research, vol. 109, no. 7, pp. 724–728, 2011. View at Publisher · View at Google Scholar
  55. K. R. Vrijsen, J. P. G. Sluijter, M. W. L. Schuchardt et al., “Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells,” Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1064–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Timmers, S. K. Lim, F. Arslan et al., “Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium,” Stem Cell Research, vol. 1, no. 2, pp. 129–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. R. C. Lai, F. Arslan, M. M. Lee et al., “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury,” Stem Cell Research, vol. 4, no. 3, pp. 214–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, and G. Vassalli, “Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 354605, 10 pages, 2012. View at Publisher · View at Google Scholar
  59. L. Chen, Y. Wang, Y. Pan et al., “Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury,” Biochemical and Biophysical Research Communications, vol. 431, no. 3, pp. 566–571, 2013. View at Publisher · View at Google Scholar
  60. R. C. Lai, T. S. Chen, and S. K. Lim, “Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease,” Regenerative Medicine, vol. 6, no. 4, pp. 481–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. N. Chaput and Thery, “Exosomes: immune properties and potential clinical implementations,” Seminars in Immunopathology, vol. 33, no. 5, pp. 419–440, 2011. View at Google Scholar
  63. J. Ratajczak, K. Miekus, M. Kucia et al., “Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery,” Leukemia, vol. 20, no. 5, pp. 847–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Ohshima, K. Inoue, A. Fujiwara et al., “Let-7 microRNA family Is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line,” PLoS ONE, vol. 5, no. 10, Article ID e13247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Fujii, Z. Sun, S. H. Li et al., “Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice,” JACC. Cardiovascular Imaging, vol. 2, no. 7, pp. 869–879, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Yaniz-Galende, J. Chen, E. Chemaly et al., “Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells,” Circulation Research, vol. 111, no. 11, pp. 1434–1445, 2012. View at Publisher · View at Google Scholar
  67. F. L. Xiang, X. Lu, L. Hammoud et al., “Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice,” Circulation, vol. 120, no. 12, pp. 1065–1074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Eulalio, M. Mano, M. Dal Ferro et al., “Functional screening identifies miRNAs inducing cardiac regeneration,” Nature, vol. 492, no. 7429, pp. 376–381, 2012. View at Publisher · View at Google Scholar
  69. T. M. Jayawardena, B. Egemnazarov, E. A. Finch et al., “MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes,” Circulation Research, vol. 110, no. 11, pp. 1465–1473, 2012. View at Publisher · View at Google Scholar
  70. X. W. Song, Q. Li, L. I. Lin et al., “MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes,” Journal of Cellular Physiology, vol. 225, no. 2, pp. 437–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. R. A. Boon, K. Iekushi, S. Lechner et al., “MicroRNA-34a regulates cardiac ageing and function,” Nature, vol. 495, no. 7439, pp. 107–110, 2013. View at Publisher · View at Google Scholar